Magnesium sulfate for subarachnoid hemorrhage: A piece of the mosaic

Stroke

Volumn 41, Issue 10, 2010, Pages

  Keller, Emanuela ^a   Muroi, Carl ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; HUMAN; HYPOCALCEMIA; HYPOTENSION; LETTER; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

HUMANS; MAGNESIUM SULFATE; SUBARACHNOID HEMORRHAGE;

EID: 77957987152     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.589903     Document Type: Letter

References (8)

1. Wong GKC, Wai SP, Chan MTV, Boet R, Gin T, Ng SCP, Zee BCY. Intravenous magnesium sulphate for aneurismal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke. 2010;41:921-926.
2. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marroco A, Thomas AJ, Mitsias PD, Malik GM. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002; 96:510-514.
3. Van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gjin J, Vermeulen M, Rinkel GJ. Magensium sulfate in aneurysmal subarachnoid hemorrhage. A randomized controlled trial. Stroke. 2005;36:1011-1015.
4. Wong GKC, Chan MTV, Boet R, Poon WS, Gin T. Intravenous magnesium sulfate after aneurysmal aneurysmal subarachnoid hemorrhage: A prospective randomized pilot study. J Neurosurg Anesthesiol. 2006;18: 142-148.
5. Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: A randomized, placebo-controlled, dose-adapted trial. Surg Neurol. 2008;69:33-39.
6. Van de Water JM, van den Bergh WM, Hoff RG, Algra A, Rinkel GJ. Hypocalcaemia may reduce the beneficial effect of magnesium treatment in aneurysmal subarachnoid hemorrhage. Magnes Res. 2007;20: 130-135.
7. Bederson JB, Conolly ES, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE, Harbaugh RE, Patel AB, Rosenwasser RH. Guidelines for the management of aneurysmal subarachnoid hemorrhage. Stroke. 2009;40: 994-1025.
8. MacDonald L, Kassell N, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A. Placebo-controlled phase 2 dose-finding trial subarachnoid hemorrhage (CONSCIOUS-1): Randomized, doubleblind, clazosentan to overcome neurological ischemia and infarction occurring after. Stroke. 2008;39:3015-3021.